Showing 2769–2784 of 5738 results

Ufenamate

Ufenamate is an anthranilic acid derivative with anti-inflammatory activity.

β-Nicotinamide Mononucleotide

Nicotinamide mononucleotide (NMN), one of the key precursors of NAD+ and products of the NAMPT reaction , is converted to NAD+ by nicotinamide mononucleotide adenylyltransferase.

Revefenacin

Revefenacin (TD-4208) is a potent, lung-selective, long-acting muscarinic antagonist that may be for the treatment of respiratory disease.

Doxapram

Doxapram is a central respiratory stimulant with a brief duration of action.

Cisapride

Cisapride is a nonselective 5-HT4 receptor agonist with gastroprokinetic effects.

Ozagrel Sodium

Sodium ozagrel (ozagrel) is a thromboxane A2 synthase inhibitor with neuroprotective properties.

Darunavir

Darunavir is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.

Coptisine Chloride

Coptisine is an isoquinoline alkaloid isolated from Coptidis Rhizoma with anti-diabetic, antimicrobial, antiviral, anti-hepatoma, and anti-leukemia effects.

Selamectin

Selamectin is a novel macrocyclic lactone of the avermectin class. It paralyses and/or kills a wide range of invertebrate parasites through interference with their chloride channel conductance causing disruption of normal neurotransmission and has adulticidal, ovicidal and larvicidal activity against fleas.

Entecavir

Entecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).

Raltegravir Potassium

Raltegravir Potassium is the orally bioavailable potassium salt of raltegravir, the first approved human immunodeficiency virus type 1 (HIV-1) integrase inhibitor.

Zoledronic Acid Monohydrate

Zoledronic acid, a nitrogen-containing bisphosphonate, is a potent osteoclast inhibitor which induces apoptosis in osteoclasts by inhibiting enzymes of the mevalonate pathway and preventing the isoprenylation of small GTP-binding proteins such as Ras and Rho.

Ruxolitinib Phosphate

Ruxolitinib Phosphate is the phosphate salt form of ruxolitinib, an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities.